A complex of histamine/mouse γ-globulin preferentially inhibits allergen-induced peritoneal accumulation of eosinophils, but not neutrophils, in mice

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 I, 1997, Pages 809-816

  Yoshii, Haruo ^a   Fukata Yamazaki, Yuriko ^a   Yamamoto, Kazuhiko ^b   Yago, Hisashi ^a   Yanagihara, Yukiyoshi ^c   Okudaira, Hirokazu ^d  

^a Nippon Zoki Pharmaceutical Co   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Complex of histamine human globulin; Complex of histamine mouse globulin; Eosinophil accumulation; Histamine; Ragweed pollen; globulin

Indexed keywords

ALBUMIN; GLUTAMINE; HISTAMINE; IMMUNOGLOBULIN;

ADOLESCENT; ALLERGY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EOSINOPHIL; FEMALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAGWEED POLLEN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031395170     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70278-1     Document Type: Article

References (43)

1. Wasserman SI. Chemotactic mediators. Rev Allergy 1983; 1:385-92.
2. Nagy L, Lee TH, Goetzl EJ, Pickett WC, Kay AB. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and their lipoxygenase products. Clin Exp Immunol 1982;47:541-9.
3. Tamura N, Agrawal DK, Suliaman FA, Townley RG. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 1987; 142:638-44.
4. Mencia-Huerta JM, Lewis RA, Razin E, Austen KF. Antigeninitiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. Immunology 1983;131:2958-64.
5. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:1701-6.
6. Pinckard RN, Ludwig JC, McManus LM. Platelet activating factor. In: Gallin JJ, Goldstein IM, Synderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press; 1988. p. 139-67.
7. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
8. +) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis 1992;145:S22-6.
9. Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992;149:629-35.
10. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
11. Mori A, Suko M, Tsuruoka N, Etoh T, Nakagawa H, Kaminuma O, et al. Atopic diseases and eosinophilic inflammation-possible management with agents which downregulate IL-5 gene transcription. Environ Dermatol 1994;1:42-54.
12. Silberstein DS, David JR. The regulation of human eosinophil function by cytokines. Immunol Today 1987;8:380-6.
13. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator for human eosinophil function. J Exp Med 1988;167:219-24.
14. Rothenberg ME, Owen WF Jr, Silberstein DS, Woods J, Soberman RJ, Austen KF, et al. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin-3. J Clin Invest 1988;81:1986-94.
15. Owen WF Jr, Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF, et al. Regulation of human eosinophil viability, density, and function by granulocyte-macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987;166:129-41.
16. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
17. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77:532-7.
18. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
19. Beasley R, Roche WR, Roberts JA, Holgate S. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-17.
20. Barnes PJ. New concepts in pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989;83:1013-26.
21. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable asthma. Am Rev Respir Dis 1990;142: 1410-3.
22. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
23. Bousouet J, Chanez P, Vignola AM, Lacoste JY, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med 1990;323: 1033-8.
24. Boscom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of systemic steroid pretreatment. Am Rev Respir Dis 1988;138:406-12.
25. Frick WE, Sedgwick JB, Busse WW. Hyposense eosinophils in allergic rhinitis. J Allergy Clin Inmunol 1988;82:119-25.
26. Ito K. Clinical evaluation of Histaglobin for bronchial asthma - a double-blind study using human γ-globulin as control (in Japanese). Rinshoutokenkyuu 1979;56:3085-69.
27. Hisamatu K, Oyama H, Fujikawa Y, Watanabe M, Haga M, Ikeda Y, et al. The clinical evaluation using a double blind technique on the effectiveness of Histaglobin on nasal allergy (in Japanese). Jibiinkokatenbo 1979;22:38-49.
28. Ito A, Yanagida N, Suzuki Y, Suzuki K, Hand M, Tanaka H, et al. Clinical effect of Histaglobin on nasal allergy double-blind study (in Japanese). Jibiinkokarinsho 1979;72:1539-51.
29. Parrot JL, Laborde C. The histamine-fixing power of blood serum. Its modification after an injection of normal human serum or azoprotein of histamine. J Physiol 1951;40:885-9.
30. Laborde C, Parrot JL, Urquia DA. Le pouir histaminopexique du serum sanguin. Thechinique de mesre. Pre Med 1953;61:1151-3.
31. Ishikawa T, Shimada T, Kessoku N, Kiyoi M. Inhibition of rat mast cell degranulation and histamine release by histamine-rat gammaglobulin conjugate. Int Arch Allergy Appl Immunol 1979;59:403-7.
32. Watanabe K, Onishi A, Seto Y, Kurimoto Y, Kiyoi M, Ishikawa T, et al. Inhibitory effect of histamine-carried rat gamma globulin on histamine release from rat mast cells. Arerugi 1979;28:666-73.
33. Ohnishi A, Watanabe K, Nakagawa T, Morita Y, Miyamoto T, et al. Inhibitory effect of histamine-added human gammaglobulin on histamine release from human leukocytes. Clin Immunol 1985;17: 1145-50.
34. Hekitani T, Morisima M, Ida M. Therapeutic effect of Histaglobin for allergic rhinitis (in Japanese). Sinyakutorinsho 1969;18:883-6.
35. Asano T. Histaglobin treatment for childhood allergic diseases (in Japanese). Shonikashinryo 1969;32:781-5.
36. Higuchi Y, Hisatoku S, Torii S, Maeshima M, Kanai A, Mori K. Histaglobin treatment for childhood asthma (in Japanese). Shonikarinsho 1968;21:1661-5.
37. Kaneko M, Yazumichi H, Takatsu K, Matsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int Arch Allergy Appl Immunol 1991;96:41-5.
38. Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES. Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care Med 1994;149:1506-11.
39. Graziano RF, Looney RJ, Shen L, Fanger MW. Fcγ R-mediated killing by eosinophils. J Immunol 1989;142:230-5.
40. Capron M. Eosinophils: receptors and mediators in hypersensitivity. Clin Exp Allergy 1989;19(Suppl 1):3-8.
41. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Hunk DA, Tomioka K, et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992;148:1086-92.
42. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;4:449-56.
43. Kukita J. A double blind study of Histaglobin on allergic dermatitis (in Japanese). Nishinipponhifuka 1980;42:470-7.